Ishikawa, Toru <br/><br/>
Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment.  [electronic resource] 

 -  Internal medicine (Tokyo, Japan)  Oct 2018 
 - 2843-2845 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1349-7235 
<br/><br/><label>Standard No.: </label>10.2169/internalmedicine.0621-17  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anilides--therapeutic use<br/>Antiviral Agents--therapeutic use<br/>Carbamates--therapeutic use<br/>Cyclopropanes<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Lactams, Macrocyclic<br/>Macrocyclic Compounds--therapeutic use<br/>Proline--analogs & derivatives<br/>Retreatment<br/>Ribavirin--therapeutic use<br/>Ritonavir--therapeutic use<br/>Sofosbuvir--therapeutic use<br/>Sulfonamides<br/>Treatment Outcome<br/>Valine